RYTM
NASDAQ · Biotechnology
Rhythm Pharmaceuticals Inc
$115.63
+3.53 (+3.15%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+12.40%
1Y
+22.61%
YTD
+10.11%
Open$113.17
Previous Close$112.10
Day High$116.18
Day Low$111.69
52W High$122.20
52W Low$74.50
Volume—
Avg Volume849.0K
Market Cap7.88B
P/E Ratio—
EPS$-3.05
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$105.86
Above
SMA 200
$92.90
Above
RSI (14)
49.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-12.6% upside
Current
$115.63
$115.63
Target
$101.09
$101.09
$80.78
$101.09 avg
$123.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 198.96M | 975.71M | 873.25M |
| Net Income | -206,075,174 | -22,144,056 | -23,253,892 |
| Profit Margin | -103.6% | -2.3% | -2.7% |
| EBITDA | -199,929,168 | -26,213,634 | -24,112,007 |
| Free Cash Flow | — | -20,824,615 | -25,629,049 |
| Rev Growth | +100.2% | -2.7% | +8.2% |
| Debt/Equity | 0.40 | 0.40 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |